CLEARANCE OF PLASMINOGEN ACTIVATORS - A MAJOR DETERMINANT OF PLASMA-CONCENTRATION - THERAPEUTIC AND DIAGNOSTIC IMPLICATIONS

被引:14
作者
COHEN, AF [1 ]
BURGGRAAF, K [1 ]
DEBOER, A [1 ]
KLUFT, C [1 ]
机构
[1] TNO,IVVO,GAUBIUS LAB,2300 AK LEIDEN,NETHERLANDS
关键词
D O I
10.1111/j.1749-6632.1992.tb51646.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
[No abstract available]
引用
收藏
页码:443 / 449
页数:7
相关论文
共 27 条
[1]  
[Anonymous], 1990, Lancet, V336, P65
[2]  
BASS L, 1976, Journal of Theoretical Biology, V61, P393, DOI 10.1016/0022-5193(76)90026-6
[3]  
BAX NDS, 1980, BRIT J CLIN PHARMACO, V10, P353
[4]  
BROMMER EJP, 1982, THROMB HAEMOSTASIS, V48, P156
[5]   COMPARISON OF BOLUS AND INFUSION METHODS FOR ESTIMATING HEPATIC BLOOD-FLOW IN PATIENTS WITH LIVER-DISEASE USING INDOCYANINE GREEN [J].
CLEMENTS, D ;
WEST, R ;
ELIAS, E .
JOURNAL OF HEPATOLOGY, 1987, 5 (03) :282-287
[6]   LIFE-STYLE AND BLOOD FIBRINOLYTIC-ACTIVITY - A COMMENT ON CLEARANCE OF PLASMINOGEN ACTIVATORS [J].
DEBOER, A ;
KLUFT, C ;
COHEN, AF .
FIBRINOLYSIS, 1990, 4 :61-63
[7]  
DEBOER A, 1992, THROMB HAEMOSTASIS, V67, P83
[8]  
DEBOER A, 1989, BR J CLIN PHARM, V96, pP228
[9]   EFFECT OF ACUTE AND CHRONIC EXERCISE ON HEPATIC DRUG-METABOLISM [J].
DOSSING, M .
CLINICAL PHARMACOKINETICS, 1985, 10 (05) :426-431
[10]  
EPSTEIN SE, 1970, LANCET, V2, P631